271 related articles for article (PubMed ID: 23893750)
41. MRI evaluation of inflammatory activity in Crohn's disease.
Sempere GA; Martinez Sanjuan V; Medina Chulia E; Benages A; Tome Toyosato A; Canelles P; Bulto A; Quiles F; Puchades I; Cuquerella J; Celma J; Orti E
AJR Am J Roentgenol; 2005 Jun; 184(6):1829-35. PubMed ID: 15908538
[TBL] [Abstract][Full Text] [Related]
42. Reproducibility of bowel ultrasonography in the evaluation of Crohn's disease.
Fraquelli M; Sarno A; Girelli C; Laudi C; Buscarini E; Villa C; Robotti D; Porta P; Cammarota T; Ercole E; Rigazio C; Senore C; Pera A; Malacrida V; Gallo C; Maconi G
Dig Liver Dis; 2008 Nov; 40(11):860-6. PubMed ID: 18583205
[TBL] [Abstract][Full Text] [Related]
43. Plain magnetic resonance imaging as an alternative in evaluating inflammation and bowel damage in inflammatory bowel disease--a prospective comparison with conventional magnetic resonance follow-through.
Jesuratnam-Nielsen K; Løgager VB; Rezanavaz-Gheshlagh B; Munkholm P; Thomsen HS
Scand J Gastroenterol; 2015 May; 50(5):519-27. PubMed ID: 25592192
[TBL] [Abstract][Full Text] [Related]
44. Impact of gadolinium-based contrast agent in the assessment of Crohn's disease activity: Is contrast agent injection necessary?
Quaia E; Sozzi M; Gennari AG; Pontello M; Angileri R; Cova MA
J Magn Reson Imaging; 2016 Mar; 43(3):688-97. PubMed ID: 26250897
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of Crohn's disease activity by MR enterography: Derivation and histopathological comparison of an MR-based activity index.
Gücer FI; Senturk S; Özkanli S; Yilmabasar MG; Köroglu GA; Acar M
Eur J Radiol; 2015 Oct; 84(10):1829-34. PubMed ID: 26123842
[TBL] [Abstract][Full Text] [Related]
46. MR enterography for assessment and management of small bowel Crohn disease.
Allen BC; Leyendecker JR
Radiol Clin North Am; 2014 Jul; 52(4):799-810. PubMed ID: 24889172
[TBL] [Abstract][Full Text] [Related]
47. [Value of contrast-enhanced MR enterography in pediatric Crohn's disease: preliminary study].
Godefroy C; Pilleul F; Dugougeat F; Yzèbe D; Lachaux A; Pracros JP; Valette PJ
J Radiol; 2005 Nov; 86(11):1685-92. PubMed ID: 16269980
[TBL] [Abstract][Full Text] [Related]
48. Diffusion-weighted magnetic resonance imaging for detecting and assessing ileal inflammation in Crohn's disease.
Buisson A; Joubert A; Montoriol PF; Da Ines D; Hordonneau C; Pereira B; Garcier JM; Bommelaer G; Petitcolin V
Aliment Pharmacol Ther; 2013 Mar; 37(5):537-45. PubMed ID: 23289713
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of noncontrast MR enterography for pediatric inflammatory bowel disease assessment.
Lanier MH; Shetty AS; Salter A; Khanna G
J Magn Reson Imaging; 2018 Aug; 48(2):341-348. PubMed ID: 29504171
[TBL] [Abstract][Full Text] [Related]
50. Correlation of magnetic resonance enteroclysis (MRE) and wireless capsule endoscopy (CE) in the diagnosis of small bowel lesions in Crohn's disease.
Tillack C; Seiderer J; Brand S; Göke B; Reiser MF; Schaefer C; Diepolder H; Ochsenkühn T; Herrmann KA
Inflamm Bowel Dis; 2008 Sep; 14(9):1219-28. PubMed ID: 18484672
[TBL] [Abstract][Full Text] [Related]
51. MR enterography correlates highly with colonoscopy and histology for both distal ileal and colonic Crohn's disease in 310 patients.
Grand DJ; Kampalath V; Harris A; Patel A; Resnick MB; Machan J; Beland M; Chen WT; Shah SA
Eur J Radiol; 2012 May; 81(5):e763-9. PubMed ID: 22445795
[TBL] [Abstract][Full Text] [Related]
52. Diffusion-weighted MR enterography for evaluating Crohn's disease: how does it add diagnostically to conventional MR enterography?
Kim KJ; Lee Y; Park SH; Kang BK; Seo N; Yang SK; Ye BD; Park SH; Kim SY; Baek S; Ha HK
Inflamm Bowel Dis; 2015 Jan; 21(1):101-9. PubMed ID: 25358063
[TBL] [Abstract][Full Text] [Related]
53. Dynamic contrast enhanced magnetic resonance imaging of the terminal ileum: differentiation of activity of Crohn's disease.
Del Vescovo R; Sansoni I; Caviglia R; Ribolsi M; Perrone G; Leoncini E; Grasso RF; Cicala M; Zobel BB
Abdom Imaging; 2008; 33(4):417-24. PubMed ID: 17639383
[TBL] [Abstract][Full Text] [Related]
54. Polyethylene glycol and contrast-enhanced MRI of Crohn's disease in children: preliminary experience.
Magnano G; Granata C; Barabino A; Magnaguagno F; Rossi U; Calevo MG; Toma P
Pediatr Radiol; 2003 Jun; 33(6):385-91. PubMed ID: 12682793
[TBL] [Abstract][Full Text] [Related]
55. [MR enterography sequence evaluation for patients with Crohn's disease].
Schleder S; Dendl LM; Pawlik M; Friedrich C; Ott C; Agha A; Wiggermann P; Stroszczynski C; Schreyer AG
Rofo; 2013 May; 185(5):440-5. PubMed ID: 23440646
[TBL] [Abstract][Full Text] [Related]
56. Magnetic Resonance enteroclysis imaging in Crohn's disease.
Broglia L; Gigante P; Papi C; Ferrari R; Gili L; Capurso L; Castrucci M
Radiol Med; 2003; 106(1-2):28-35. PubMed ID: 12951548
[TBL] [Abstract][Full Text] [Related]
57. MR of the small bowel with a biphasic oral contrast agent (polyethylene glycol): technical aspects and findings in patients affected by Crohn's disease.
Laghi A; Paolantonio P; Iafrate F; Borrelli O; Dito L; Tomei E; Cucchiara S; Passariello R
Radiol Med; 2003; 106(1-2):18-27. PubMed ID: 12951547
[TBL] [Abstract][Full Text] [Related]
58. MRI scoring system including dynamic motility evaluation in assessing the activity of Crohn's disease of the terminal ileum.
Girometti R; Zuiani C; Toso F; Brondani G; Sorrentino D; Avellini C; Bazzocchi M
Acad Radiol; 2008 Feb; 15(2):153-64. PubMed ID: 18206614
[TBL] [Abstract][Full Text] [Related]
59. Noninvasive multidetector computed tomography enterography in patients with small-bowel Crohn's disease: is a 40-second delay better than 70 seconds?
Vandenbroucke F; Mortelé KJ; Tatli S; Pelsser V; Erturk SM; De Mey J; Silverman SG
Acta Radiol; 2007 Dec; 48(10):1052-60. PubMed ID: 17963078
[TBL] [Abstract][Full Text] [Related]
60. Shortened oral contrast preparation for improved small bowel distension at MR enterography.
Bekendam MIJ; Puylaert CAJ; Phoa SKSS; Nio CY; Stoker J
Abdom Radiol (NY); 2017 Sep; 42(9):2225-2232. PubMed ID: 28393302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
